Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

CD59 incorporation protects hepatitis C virus against complement-mediated destruction.

Amet T, Ghabril M, Chalasani N, Byrd D, Hu N, Grantham A, Liu Z, Qin X, He JJ, Yu Q.

Hepatology. 2012 Feb;55(2):354-63. doi: 10.1002/hep.24686. Epub 2011 Dec 16.

2.

The role of humoral innate immunity in hepatitis C virus infection.

Tarr AW, Urbanowicz RA, Ball JK.

Viruses. 2012 Jan;4(1):1-27. doi: 10.3390/v4010001. Epub 2012 Jan 5. Review.

3.

Immunity in hepatitis C virus infection.

Prince AM.

Vox Sang. 1994;67 Suppl 3:227-8. Review.

PMID:
7526553
4.

The good and evil of complement activation in HIV-1 infection.

Yu Q, Yu R, Qin X.

Cell Mol Immunol. 2010 Sep;7(5):334-40. doi: 10.1038/cmi.2010.8. Epub 2010 Mar 15. Review.

5.

Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review).

Maio M, Brasoveanu LI, Coral S, Sigalotti L, Lamaj E, Gasparollo A, Visintin A, Altomonte M, Fonsatti E.

Int J Oncol. 1998 Aug;13(2):305-18. Review.

PMID:
9664126
6.

Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.

Blaising J, P├ęcheur EI.

Biochimie. 2013 Jan;95(1):96-102. doi: 10.1016/j.biochi.2012.07.016. Epub 2012 Aug 1. Review.

PMID:
22884392
7.

Hepatitis C virus: a new class of virus associated with particles derived from very low-density lipoproteins.

Ye J.

Arterioscler Thromb Vasc Biol. 2012 May;32(5):1099-103. doi: 10.1161/ATVBAHA.111.241448. Review.

Supplemental Content

Support Center